openPR Logo
Press release

Global Urinalysis Market Size to grow at a CAGR of 9.10% to reach USD 9,021.90 million by 2032, Evaluates DelveInsight

11-19-2025 10:01 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Global Urinalysis Market Size to grow at a CAGR of 9.10% to reach

According to DelveInsight's analysis, the growing incidence of urinary conditions including UTIs, chronic kidney diseases, and hospital-acquired infection is significantly boosting the need for urinalysis, as early detection plays a vital role in effective treatment. Rising health awareness and various public health initiatives are also encouraging routine screenings, prompting individuals to undergo timely diagnostic tests. Educational programs by healthcare organizations further highlight the importance of urinalysis in preventive healthcare. In addition, ongoing product innovation by major market players is bringing advanced, easy-to-use urinalysis tools to the market, improving both diagnostic precision and workflow efficiency

DelveInsight's "Urinalysis Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Urinalysis companies actively working in the market.

To know more about why North America is leading the market growth in the Urinalysis market, get a snapshot of the report Urinalysis Market Trends
https://www.delveinsight.com/sample-request/urinalysis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Urinalysis Overview
Urinalysis is a simple, routine diagnostic test that examines a urine sample to assess overall health and detect various medical conditions. It involves evaluating the urine's physical appearance, chemical composition, and microscopic elements such as cells, crystals, or microbes. Urinalysis is commonly used to diagnose urinary tract infections (UTIs), kidney diseases, metabolic disorders, and conditions like diabetes. It is quick, non-invasive, and often part of regular health checkups or pre-surgical evaluations.

DelveInsight Analysis: TThe urinalysis market size reached a value of USD 4,510.55 million in 2024 and is projected to grow at a CAGR of 9.10% from 2025 to 2032, ultimately reaching USD 9,021.90 million by 2032.

Urinalysis Market Insights
Geographically, North America is projected to hold the largest share of the urinalysis market in 2024. This growth is fueled by the increasing incidence of urinary conditions such as UTIs, kidney disorders, and diabetes, all of which drive the need for diagnostic testing. The region's strong healthcare infrastructure and extensive use of advanced diagnostic tools-including automated urine analyzers and point-of-care systems-further contribute to market expansion. Additionally, rising awareness of preventive care and the value of routine health screenings promotes more frequent urinalysis testing. Supportive government initiatives and regulatory approvals for new, innovative products also enhance market access and adoption across the region.

To read more about the latest highlights related to Urinalysis, get a snapshot of the key highlights entailed in the Urinalysis Insights
https://www.delveinsight.com/report-store/urinalysis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Urinalysis Market Report
• In August 2024, Carolina Liquid Chemistries and Medline partnered to distribute fentanyl screening tests for urinalysis.
• In July 2024, Mexple launched UroMen and UroWomen urine collection kits.
• Thus, owing to such developments in the market, rapid growth will be observed in the Urinalysis market during the forecast period

Key Players in the Urinalysis Market
Some of the key market players operating in the Urinalysis market include- F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Siemens Healthcare Private Limited, Sysmex Europe SE, Abott, Carolina Liquid Chemistries, Medline Industries, LP, Mexple, Olive Diagnostics, ACON Laboratories, Thermo Fisher Scientific, Arkray, Inc., DIRUI Industrial Co., Ltd., Mindray Medical International, Eiken Chemical Co., Ltd., Greiner Bio-One, LabCorp, Sekisui Diagnostics, Teco Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and others.

Which MedTech key players in the Urinalysis market are set to emerge as the trendsetter explore @ Key Urinalysis Companies
https://www.delveinsight.com/sample-request/urinalysis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Urinalysis Market Landscape
Furthermore, automated analyzers are helping broaden the availability of high-quality urinalysis services to smaller clinics and diagnostic labs, increasing access to advanced diagnostic tools. A continued focus on product innovation and technological progress is also strengthening market growth. For instance, in September 2022, Sysmex Corporation introduced the UF-1500, a fully automated urine particle analyzer for sediment evaluation, which preserves the strong performance and ease of use of the UF-5000 while integrating enhancements based on user requirements.
Collectively, these factors are anticipated to fuel the expansion of the automated urine analyzers segment, thereby supporting the overall growth of the global urinalysis market."

Scope of the Urinalysis Market Report
• Coverage: Global
• Study Period: 2022-2032
• Urinalysis Market Segmentation By Product: Instruments [Automated Urine Analyzers, Semi-automated Urine Analyzers, and Point-of-Care Testing Urinalysis] and Consumables [Chemical/Reagent, Kits, and Others
• Urinalysis Market Segmentation By Test Type: Biochemical Urinalysis, Microscopic Urinalysis, and Others
• Urinalysis Market Segmentation By End-User: Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, and Others
• Urinalysis Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Urinalysis Companies: F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Siemens Healthcare Private Limited, Sysmex Europe SE, Abott, Carolina Liquid Chemistries, Medline Industries, LP, Mexple, Olive Diagnostics, ACON Laboratories, Thermo Fisher Scientific, Arkray, Inc., DIRUI Industrial Co., Ltd., Mindray Medical International, Eiken Chemical Co., Ltd., Greiner Bio-One, LabCorp, Sekisui Diagnostics, Teco Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Urinalysis market will grow by 2032? Click to get a snapshot of the Urinalysis Market Analysis
https://www.delveinsight.com/sample-request/urinalysis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Urinalysis Market Size to grow at a CAGR of 9.10% to reach USD 9,021.90 million by 2032, Evaluates DelveInsight here

News-ID: 4278825 • Views:

More Releases from DelveInsight Business Research

Pharmaceutical Cartridges Market to Reach USD 2.69 Billion by 2032, Growing at a 7.39% CAGR: DelveInsight Analysis
Pharmaceutical Cartridges Market to Reach USD 2.69 Billion by 2032, Growing at a …
According to DelveInsight's assessment, the pharmaceutical cartridges market is experiencing robust growth, primarily driven by the rising burden of chronic diseases that necessitate long-term and regular medication administration. In addition, the increasing adoption of self-injection therapies and the growing inclination toward home-based healthcare solutions are significantly supporting market expansion. Continuous innovations in drug delivery technologies are further accelerating growth by improving ease of use, ensuring accurate dosing, and enhancing patient
Global Nucleic Acid Amplification Testing Market Forecast 2025-2032: 8.13% CAGR Fueled by R&D and Diagnostics Innovation, estimates DelveInsight
Global Nucleic Acid Amplification Testing Market Forecast 2025-2032: 8.13% CAGR …
According to DelveInsight's evaluation, the increasing adoption of Nucleic Acid Amplification Testing (NAAT) is largely attributed to the rising burden of infectious and hereditary disorders worldwide. Furthermore, the growing prevalence of cancer and intensified research and development initiatives by leading industry participants are significantly contributing to market expansion. Collectively, these factors are expected to drive sustained growth of the NAAT market during the forecast timeframe from 2025 to 2032. DelveInsight's report
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market Forecast 2034: Intellia's CRISPR Advance Signals a New Era for Transthyretin Amyloid Cardiomyopathy Treatment | DelveInsight
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market Forecast 2034: I …
DelveInsight's newly published report, "Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Insights, Epidemiology, and Market Forecast - 2032," delivers a comprehensive assessment of the ATTR-CM market across the seven major markets (7MM), encompassing the United States, EU4, the United Kingdom, and Japan. The report offers detailed insights into disease epidemiology, evolving treatment approaches, and shifting market trends, with projections extending through 2032. Intellia Therapeutics recently reported promising longer-term Phase 1 outcomes for its
Systemic Lupus Erythematosus Market Size in the 7MM was around USD 3,200 million in 2023 and expected to grow by 2034, estimates DelveInsight
Systemic Lupus Erythematosus Market Size in the 7MM was around USD 3,200 million …
The US dominates the Systemic Lupus Erythematosus (SLE) market, accounting for about 82% of total market share, with BENLYSTA leading among approved therapies. SLE is a chronic autoimmune disease that predominantly affects women (around 90%), with the US representing nearly half of total cases across the 7MM, and about 51% classified as moderate severity. Treatment typically begins with NSAIDs and antimalarials, followed by glucocorticoids and immunosuppressants, while BENLYSTA and SAPHNELO remain

All 5 Releases


More Releases for Urinalysis

Geriatric Population Surge Fuels Growth In The Urinalysis Market: An Emerging Dr …
The Urinalysis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Urinalysis Market? The size of the urinalysis market has witnessed significant growth over the last few years. It is projected to rise from a valuation of $3.57 billion in
Global Urinalysis Strips Market Size by Application, Type, and Geography: Foreca …
USA, New Jersey- According to Market Research Intellect, the global Urinalysis Strips market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The market for urinalysis strips is steadily growing due to the rising incidence of renal disorders, diabetes, and urinary tract infections (UTIs). The ease of
Urinalysis Test Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Urinalysis Test Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. Urinalysis Test Market Definition, With Current Market Values The urinalysis test market encompasses the development, production, and distribution of diagnostic products and services used to analyze
Urinalysis Market Demand for Urinalysis Is Expected To Provide Opportunities for …
Urinalysis Market Outlook 2022-2029 The Urinalysis Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors. Market Analysis and Size The global urinalysis market is expected to grow at more than 7.2% CAGR from 2022 to 2029. It is expected to reach above USD 6.1 billion by 2029
Urinalysis Market
A urinalysis is a test that measures elements found in urine, such as electrolytes, hormones, or waste products of metabolism. It is also called urine test and involves a number of tests to detect and measure various compounds that pass through the urine. This examination can help find problems that need treatment, including infections or kidney problems.  A urine test includes three parts namely, visual exam, microscopic exam, and dipstick
Urinalysis Market
A urinalysis is a test that measures elements found in urine, such as electrolytes, hormones, or waste products of metabolism. It is also called urine test and involves a number of tests to detect and measure various compounds that pass through the urine. This examination can help find problems that need treatment, including infections or kidney problems.  A urine test includes three parts namely, visual exam, microscopic exam, and dipstick